Skip to main content

Table 2 Laboratory parameters at diagnosis

From: Kidney REPLACEment therapies in patients with acute kidney injury and RHABDOmyolysis (ReplaceRhabdo): a pilot trial

Parameter

All n = 15

CVVH n = 5

CVVHD-HCO n = 5

CVVHD-CS n = 5

p

Myoglobin (µg/l)

9791 [6522; 27931]

17560 [8157; 23816]

7692 [6434; 19938]

7773 [4821; 28966]

0.689

CK (µkat/l)

133 [44; 367]

212 [132; 344]

68 [47; 254]

37 [20; 367]

0.497

Urea (mmol/l)

17.0 [12.0; 28.0]

23.0 [11.5; 32.5]

19.0 [10.5; 27.5]

16.0 [12.0; 22.5]

0.733

Creatinine (µmol/l)

296 [179; 362]

296 [228; 351]

362 [132; 441]

275 [166; 659]

0.925

Phosphate (mmol/l)

1.98 [0.96; 2.68]

2.29 [1.11; 3.62]

1.15 [0.91; 2.44]

1.82 [1.03; 3.28]

0.659

Calcium (mmol/l)

1.95 [1.73; 2.2]

1.9 [1.77; 1.97]

2.07 [1.82; 2.33]

1.79 [1.70; 2.23]

0.589

Magnesium (mmol/l)

1.05 [0.95; 1.15]

1.15 [1.06; 1,27]

0.99 [0.79; 1.1]

1.04 [0.94; 1.13]

0.121

Sodium (mmol/l)

139.0 [132.0; 142.0]

137.0 [131.5; 143.0]

139.0 [138.5; 141.5]

141.0 [132.0; 144.5]

0.488

Potassium (mmol/l)

4.7 [4.6; 5.3]

5.2 [4.7; 5.6]

4.6 [4.1; 5.2]

4.7 [4.35; 5.1]

0.247

pH

7.32 [7.31; 7.41]

7.32 [7.27; 7.34]

7.39 [7.25; 7.42]

7.32 [7.27; 7.42]

0.481

Bicarbonate (mmol/l)

19.7 [16.7; 27.7]

16.7 [15.3; 30.4]

22.0 [17.75; 31.0]

19.7 [16.5; 26.8]

0.651

Base excess (mmol(l)

-4.1 [-9.7; 3.3]

-8.8 [-10.05; 3.85]

-3.3 [-7.15; 6.3]

-4.1 [-8.85; 1.8]

0.651

Lactate (mmol/l)

2.2 [1.5; 2.5]

2.4 [2.25; 2.85]

2.1 [1.0; 2.35]

1.6 [1.25; 3.6]

0.295

Hemoglobin (mmol/l)

6.0 [4.4; 6.9]

6.9 [5.65; 7.85]

5.2 [4.2; 8.1]

4.5 [4.3; 6.4]

0.195

Leukocytes (109/l)

16.7 [8.1; 18.8]

7.8 [6.3; 21.2]

17.1 [13.5; 18.65]

16.7 [9.95; 28.7]

0.468

Platelets (109/l)

183.0 [100.0; 252.0]

162.0 [55.0; 194.0]

187.0 [162.5; 284.0]

201.0 [77.0; 270.5]

0.310

  1. Data presented as median [25th, 75th quantile]
  2. CK creatin kinase, CS CytoSorb®, CVVH continuous veno-venous hemofiltration, CVVHD continuous veno-venous hemodialysis, HCO high cut-off